Australia markets closed

Vita Life Sciences Limited (VLS.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
2.2000-0.0100 (-0.45%)
At close: 02:53PM AEST

Vita Life Sciences Limited

Bath Road
Unit 1/102
Kirrawee, NSW 2232
61 2 9545 2633

IndustryDrug Manufacturers - Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Andrew W. O'KeefeMD & Director622.29kN/AN/A
Mr. Chin Leng Khoo AGIA, C.A., C.P.A., M.B.A.CFO & Company Secretary268.77kN/AN/A
Ms. Melissa PereiraGroup Marketing Manager142.1kN/AN/A
Mr. Shaun RutherfordChief Executive Officer of Australia424.9kN/AN/A
Ms. June LauGeneral Manager of Operations & Business SupportN/AN/AN/A
Alexandra WardTechnical & NPD ManagerN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritionals; urinary health; weight management; immunity; skin, hair, and nails; liver and digestion; fertility, pregnancy, and postpartum; blood sugar management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidants; bones, joints, and muscles; and eye health. The company markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.

Corporate governance

Vita Life Sciences Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.